创新药概念盘初调整 福元医药跌停

Group 1 - The innovative drug concept sector experienced fluctuations in early trading, with several companies facing significant declines [1] - Fuyuan Pharmaceutical hit the daily limit down, indicating a strong negative market reaction [1] - Frontier Biotech dropped over 10%, reflecting investor concerns in the sector [1] Group 2 - Other companies such as Baihua Pharmaceutical, Jimin Health, Shutaishen, Bailitianheng, and Chengdu Xian Dao also saw declines exceeding 5% [1]